This study provides the first in vivo human evidence that ceramides with longer acyl chains confer superior improvements in skin barrier function compared with shorter-chain ceramides. These findings highlight the critical role of acyl chain length in ceramide-mediated barrier enhancement and support the rational design of ceramide-based formulations for optimized skin barrier restoration.
Gwon et al. (2026) studied this question.